Construction of a full-cycle management model for T2DM patients led by clinical pharmacists
- VernacularTitle:临床药师主导的T2DM患者全周期管理模式构建
- Author:
Yuanyuan JIANG
1
;
Guimei ZHENG
2
;
Yaohua CAO
2
;
Zeyu XIE
2
;
Weiling CAO
2
Author Information
1. College of Pharmacy，Dali University，Yunnan Dali 671000，China;Dept. of Pharmacy，Shenzhen Luohu People’s Hospital，Guangdong Shenzhen 518000，China
2. Dept. of Pharmacy，Shenzhen Luohu People’s Hospital，Guangdong Shenzhen 518000，China
- Publication Type:Journal Article
- Keywords:
clinical pharmacist;
type 2 diabetes mellitus
- From:
China Pharmacy
2026;37(1):92-98
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To establish a full-cycle management model for type 2 diabetes mellitus （T2DM） patients led by clinical pharmacists. METHODS Based on literature research， a basic framework and items of full-cycle management model led by clinical pharmacists were initially formulated. The Delphi method was adopted to conduct questionnaire inquiries among 26 experts to determine the specific implementation items of the model. The analytic hierarchy process （AHP） method was used to determine the weight values of items at all levels， and the reliability and validity of the model items were analyzed. RESULTS The recovery rates of the two rounds of expert consultation questionnaires were 86.67% and 100%， respectively， and the expert authority coefficient was 0.88. Kendall’s concordance coefficients of the tertiary-level items were 0.064 and 0.084， respectively， and the P values from the χ 2 tests were all less than 0.05； the consistent ratios of the judgment matrices for all levels of AHP model were all less than 0.1. The established full-cycle management led by clinical pharmacists comprised three primary-level items （pharmacy service pathway for T2DM patients during hospitalization， pharmacy management pathway for hypoglycemia in T2DM inpatients， and the pharmacy follow-up pathway for T2DM discharged patients， with weights of 0.098， 0.568 and 0.334， respectively）， twelve secondary-level items （e.g. pharmaceutical care during hospitalization for 1 to 2 days， admission assessment and education， with weights ranging from 0.143 to 0.333） and thirty-seven tertiary-level items （e.g. assessment of medication compliance， verification of the medication plan for discharge， with weights ranging from 0.068 to 0.750）. Cronbach’s α coefficients for primary-level items and the overall questionnaire were 0.762， 0.879， 0.928 and 0.951， respectively. The item-level and scale-level content validity indexes were 0.967 and 0.808， respectively. CONCLUSIONS A full-cycle management model for T2DM patients led by clinical pharmacists has been constructed successfully， demonstrating high scientificity and reliability.
